Serotonin-mediated increase in prefrontal cortex dopamine release: Pharmacological characterization

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 40-47

  Iyer, Raj N ^a   Bradberry, Charles W ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WHVA/116A2 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; BEMESETRON; BROLAMFETAMINE; DOPAMINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN 1B AGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DOPAMINE RELEASE; DRUG BINDING; MOLECULAR INTERACTION; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SEROTONIN RELEASE;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROBENZENES; MICRODIALYSIS; PIPERIDINES; PREFRONTAL CORTEX; RATS; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 0030439221     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. ABERCROMBIE, E. D., KEEFE, K. A., DIFRISCHIA, D. S. AND ZIGMOND, M. J.: Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52: 1655-1658, 1989.
2. BENLOUCIF, S. AND GALLOWAY, M. P.: Facilitation of dopamine release in vivo by serotonin agonists: Studies with microdialysis. Eur. J. Pharmacol. 200: 1-8, 1991.
3. BENLOUCIF, S., KEEGAN, M. J. AND GALLOWAY, M. P.: Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J. Pharmacol. Exp. Ther. 263: 373-377, 1993.
4. 3 receptor releases dopamine from rat striatal slice. Eur. J. Pharmacol. 155: 349-350, 1988.
5. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: A microdialysis study in the halothane-anesthetized rat. Neuropharmacology 34: 289-279, 1995.
6. BRADBERRY, C. W., LORY, J. D. AND ROTH, R. H.: The anxiogenic β-carboline FG 7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis. J. Neurochem. 56: 748-752, 1991a.
7. BRADBERRY, C. W. AND ROTH, R. H.: Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci. Lett 103: 97-102, 1989.
8. BRADBERRY, C. W., SPROUSE, J. S., AGHAJANIAN, G. K. AND ROTH, R. H.: Subpicogram determination of serotonin using HPLC with electrochemical detection, for microdialysis studies of serotonin release. In Kynurenine and Serotonin Pathways, ed. by R. Schwarzc, S. N. Young and R. R. Brown, pp. 81-89, Plenum Press, New York. 1991b.
9. 1B agonist. J. Pharmacol. Exp. Ther. 263: 318-326, 1992.
10. CAMERON, D. L. AND WILLIAMS, J. T.: Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14: 6763-6767, 1994.
11. 3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse 10: 264-266, 1992.
12. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543: 354-357, 1991.
13. 1B/1D receptor ligands. Pharmacol. Ther. 62: 385-405, 1994.
14. 1D antagonist. J. Med. Chem, 37: 2253-2257, 1994.
15. DE BELLEROCHE, J. S. AND BRADFORD, H. F.: Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: A comparison between the effects of 5-hydroxytryptamine, acetylcholine, and glutamate. J. Neurochem. 35: 1227-1234, 1980.
16. DEUTCH, A. Y. AND ROTH, R. H.: The determinants of stress-induced activation of the prefrontal cortical dopamine system. [Review]. Progr. Brain Res. 85: 367-402, 1990.
17. ENGEL, G., GOTHERT, M., HOYER, D., SCHLICKER, E. AND HILLENBRAND, K.: Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 332: 1-7, 1986.
18. ENNIS, C., KEMP, J. D. AND COX, B.: Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J. Neurochem. 36: 1515-1520, 1981.
19. 3H]-5-hydroxytryptamine. Br. J. Pharmacol. 88: 677-684, 1986.
20. FIBIGER, H. C. AND MILLER, J. J.: An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat. Neuroscience 2: 975-987, 1977.
21. FOZARD, J. R.: MDL 72222: A potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 326: 36-44, 1984.
22. FOZARD, J. K.: Agonists and Antagonists of 5-HT3 Receptors, Kluwer, Dordrecht, 1990.
23. 1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse 15: 90-92, 1993.
24. GOLDMAN-RAKIC, P. S.: Cellular and circuit basis of working memory in prefrontal cortex of nonhuman primates. [Review]. Progr. Brain Res. 85: 325-335, 1900.
25. A receptor antagonists on extracellular dopamine levels. Brain Res. 599: 51-56, 1992.
26. HERVE, D., PICKEL, V. M., JOH, T. H. AND BEAUDET, A.: Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons. Brain Res. 485: 71-83, 1987.
27. HJORTH, S., SUCHOWSKI, C. S. AND GALLOWAY, M. P.: Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain. Synapse 19: 170-176, 1935.
28. 1B receptor agonist CP-93.129 suppresses rat hippocampal 5-HT release in vivo: Comparison with RU 24969. Eur. J. Pharmacol. 209: 249-252, 1991.
29. HOYER, D., CLARKE, D. E., FOZARD, J. R., HARTIG, P. R., MARTIN, G. R., MYLECHARANE, E. J., SAXENA, P. R. AND HUMPHREY, P. P. A.: International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 157-203, 1994.
30. HOYER, D. AND MIDDLEMISS, D. N.: Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. [Review]. Trends Pharmacol. Sci. 10: 130-132, 1989
31. HUTSON, P. H., DONOHOE, T. P. AND CURZON, G.: Infusion of the 5-hydroxytryptamine agonists RU34969 aad TEMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 95: 550-552, 1988.
32. 1B mediated enhancement of extracellular dopamine in the prefrontal cortex does not occur via decreased GABA efflux. Soc. Neurosci. Abst. 21: 368, 1995.
33. 3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: A comparison with release elicited by potassium, N-methyl-D-aspartate, glutamic acid and d-amphetamine. J. Pharmacol. Exp. Ther. 262: 356-364, 1992.
34. JIANG, L. H., ASHBY, C., JR., KASSER, R. J. AND WANG, R. Y.: The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study. Brain Res. 513: 156-60, 1990.
35. 3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol. 132: 269-276, 1986.
36. JOHNSON, R. D, AND JUSTICE, J. B.: Model studies for brain dialysis. Brain Res. Bull. 10: 567-571, 1983.
37. 1B receptors block the GABAB synaptic potential in rat dopamine neurons. J. Neurosci. 12: 2000-2006, 1932.
38. KELLAND, M. D., FREEMAM, A. S. AND CHIODO, L. A.: Serotonergic afferent regulation, of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J. Pharmacol. Exp. Ther. 253: 803-811, 1990.
39. 1B receptors; Hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology 96: 93-100, 1988.
40. 1B receptor agonist CP-94,253. Drug Devel. Res. 26: 241-250, 1992.
41. 1D in the rabbit and guinea-pig brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 343: 353-364, 1991.
42. (2A) receptor antagonist. Eur. J. Pharmacol. 259: 137-141, 1994.
43. MAURA, G., FEDELE, E. AND RAJTERJ, M.: Acetylcholine release from rat hippocampal slices is modulated by 5-hydroxytryptamine. Eur. J. Pharmacol. 165: 173-179, 1989.
44. MELTZER, H. Y.: Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia. [Review]. Psychopharmacology 99: S18-S27, 1989.
45. MIDDLEMISS D. N.: The putative 5-HT1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. J. Pharm. Pharmacol. 37: 434-437, 1985.
46. MURAI, T., KOSHIKAWA, N., KANAYAMA, T., TAKADA, K., TOMIYAMA, K. AND KOBAYASHI, M.: Opposite effects of midazolam and beta-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. Eur. J. Pharmacol. 261: 65-71, 1994.
47. 3H]dopamine from rat nucleus accumbens and striatal slices. Neurochem. Res. 13: 403-407, 1988.
48. 1 agonist RU 24969 in globus pallidus-lesioned rats. Neurosci. Lett. 67: 113-118, 1986.
49. OLIVIER, B. AND MOS, J.: Rodent models of aggressive behavior and serotonergic drugs. [Review]. Progr. Neuro-Psychopharmacol. Biol. Psychiatry 16: 847-870, 1992.
50. 3 mediated control of dopaminergic function. Psychopharmacology 112: S60-S67, 1993.
51. PARSONS, L. H. AND JUSTICE, J., JR.: Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606: 195-199, 1993.
52. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
53. PEHEK, E. A., MELTZER, H. Y. AND YAMAMOTO, B. K.: The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux. Eur. J. Pharmacol 240: 107-109, 1993.
54. PESSIA, M., JIANG, Z. G., NORTH, R. A. AND JOHNSON, S. W.: Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 654: 324-330, 1994.
55. 1B receptor Science (Wash. DC) 265: 1875-1878, 1994.
56. 3H]dopamine. Eur. J. Pharmacol. 167: 309-310, 1989.
57. 2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur. J. Pharmacol. 273: 273-279, 1995.
58. 1 receptor. Eur. J. Pharmacol. 157: 173-181, 1988.
59. 3 receptor antagonist, on A9 and A10 dopamine neurons. Eur. J. Pharmacol. 163: 115-118, 1989.
60. STEINBUSCH, H. W., VAN DER KOOY, D., VERHOFSTAD, A. A. AND PELLEGRINO, A.: Serotonergic and non-serotonergic projections from the nucleus raphe dorsalis to the caudate-putamen complex in the rat, studied by a combined immunofluorescence and fluorescent retrograde axonal labeling technique Neurosci. Lett. 19: 137-142, 1980.
61. 2 receptors. J. Pharmacol. Exp. Ther. 266: 1374-1384, 1993.
62. TRENT, F. AND TEPPER, J. M.: Dorsal raphe stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo. Exp. Brain Res. 84: 620-630, 1991.
63. VAN DER KOOY, D. AND HATTORI, T.: Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: A fluorescent retrograde double labeling study in the rat. Brain Res. 186: 1-7, 1980.
64. 3H]dopamine by serotonin from superfused rat striatal slices. Neurosci. Lett. 28: 205-209, 1982.
65. WOLF, M. E. AND ROTH, R. H.: Autoreceptor regulation of dopamine synthesis. [Review]. Ann. N. Y. Acad. Sci. 604: 323-343, 1990.
66. YADID, G., PACAK, K., KOPIN, I. J. AND GOLDSTEIN, D. S.: Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol Exp. Ther. 270: 1158-1165, 1994.
67. 3H]dopamine release from rat striatal synaptosomes. Eur. J. Pharmacol. 199: 185-189, 1991.